Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Agilent Introduces New Color for Cancer Diagnosis

Agilent Technologies Inc.
Posted on: 15 Mar 18

Agilent Technologies Inc. (NYSE: A) today announced the release of a new proprietary color for immunohistochemistry: HRP Magenta for Dako Omnis. The excellent staining characteristics of the new chromogen make it particularly useful for assessment of skin and lung tissue.

“By making our innovative chromogen HRP Magenta available to our customers, we provide the means for crisp and clean stains in a bright color that is easily identified and differentiated from brown pigmentation,” said Christian Sauber, vice president and general manager of Agilent’s Pathology Division.

When diagnosing cancer, pathologists typically stain tumor samples with a brown stain called DAB. However, for skin and lung biopsies, they usually choose a red stain as it contrasts well with the brown melanin color in skin, and any pollution artifacts that are typical in lung tissue.

“Nice contrast, very distinct and very clear,” said Herr. Professor Dr. Med. Glen Kristiansen, University Hospital Bonn, Germany, when introduced to the HRP Magenta stain.

HRP Magenta has a transparent nature, yet is clearly visible, distinct and intense. This allows the pathologist to recognize tissue structures and cellular details even in strongly stained cases. Nuclei can be easily identified, and all details are visible.

HRP Magenta is designed for use on Dako Omnis, the company’s flagship instrument for immunohistochemistry and in situ hybridization. Derived from a well-known chromogen used for many years in other industries, the molecule has been modified for use in cancer diagnostics.

HRP Magenta, used with the Dako EnVision FLEX visualization system for Dako Omnis, enables laboratories to stain with two colors—brown and magenta—occupying only few additional vial spaces in the instrument. This added flexibility is expected to enable a leaner workflow with quicker turnaround times for faster patient diagnoses.

The product is being launched first in the United States and Europe, other countries will follow.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to customers’ most challenging questions. The company generated revenues of $4.47 billion in fiscal 2017 and employs 14,200 people worldwide. Information about Agilent is available at www.agilent.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180315005783/en/

Business Wire
www.businesswire.com

Last updated on: 15/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.